ACYCLOVIR FOR NEONATAL HERPES SIMPLEX VIRUS LIMITED TO SKIN, EYE, & MOUTH

阿昔洛韦治疗仅限于皮肤、眼睛、新生儿单纯疱疹病毒

• 批准号: 3783479
• 负责人: RICHARD J. WHITLEY
• 金额: --
• 依托单位: UNIVERSITY OF ALABAMA AT BIRMINGHAM
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3783479
• 关键词: Herpes simplex disease; acyclovir; eye disorder chemotherapy; eye infections; herpes simplex virus 1; human subject; human therapy evaluation; microorganism disease chemotherapy; newborn human (0-6 weeks); oral pharyngeal disorder; skin disorder chemotherapy; skin infection

Babies with neonatal herpes simplex virus limited to the skin, eye and mouth will be treated for 10 days with routine doses of acyclovir. Upon completion, the child is eligible for enrollment into the suppressive study of cutaneous herpes simplex virus infection.

新生儿单纯疱疹病毒仅限于皮肤，眼睛和 口腔将用常规剂量的阿昔洛韦治疗10天。 后 完成后，儿童有资格入组抑制性研究 皮肤单纯疱疹病毒感染